Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca tickstock newsroom · 23:13, 21 May 2026
Broker calls AstraZeneca pipeline news “frenetic”, repeats Sell rating tickstock newsroom · 15:16, 21 May 2026
EMV Capital commercial update spotlights XF-73 as it moves toward Phase 3 tickstock newsroom · 14:59, 21 May 2026
IXICO wins £1.3m Alzheimer's and Huntington's clinical analytics contracts tickstock newsroom · 13:58, 21 May 2026
4basebio wins opDNA supply deal for Phase II immunotherapy trial tickstock newsroom · 07:16, 21 May 2026
Big Pharma's AI arms race intensifies as Bristol Myers Squibb hands Anthropic the keys to the enterprise tickstock newsroom · 19:07, 20 May 2026
Mears Group wins £240m Thurrock repairs and investment contract tickstock newsroom · 11:48, 19 May 2026
Health & Bio Today: AstraZeneca wins dual FDA approvals, Advanced Medical Solutions, CelLBxHealth, GSK tickstock newsroom · 07:31, 19 May 2026
Stockbroker sticks with a Buy on Advanced Medical Solutions after suitor slips away tickstock newsroom · 11:30, 18 May 2026
CelLBxHealth to deploy Parsortix with AdventHealth for two US clinical studies tickstock newsroom · 09:34, 18 May 2026
ValiRx raises up to £1.155m to fund McGill in‑licence, Cytolytix preclinical work and animal‑health expansion tickstock newsroom · 09:00, 18 May 2026
AstraZeneca secures US approval for blood pressure drug Baxfendy tickstock newsroom · 08:49, 18 May 2026
Spire Healthcare receives 250p per-share takeover proposal from Toscafund tickstock newsroom · 09:24, 15 May 2026
AstraZeneca says Imfinzi plus enfortumab vedotin improves survival in muscle‑invasive bladder cancer tickstock newsroom · 08:51, 15 May 2026
Health & Bio Today: Adaptix wins CE mark for Ortho350, Physiomics, IXICO, Novo Nordisk tickstock newsroom · 19:02, 12 May 2026
IP Group's Enterprise Therapeutics hits primary endpoint in Phase 2 cystic fibrosis trial tickstock newsroom · 18:55, 12 May 2026
Avingtrans unit Adaptix wins CE mark for Ortho350, clears path to UK and EU sales tickstock newsroom · 09:35, 12 May 2026
RUA Life Sciences spins out RUA Structural Heart and secures funding tickstock newsroom · 09:32, 12 May 2026
The Premarket Brief: Marston's reaffirms FY2026 guidance on margin gains, Angling Direct, Greggs, Wickes, Novo Nordisk, Wizz Air tickstock newsroom · 08:25, 12 May 2026
Novo Nordisk says early responders to Wegovy 7.2 mg lose 27.7% at 72 weeks tickstock newsroom · 07:58, 12 May 2026
Abingdon Health CDMO helps launch LVOne stroke triage test in UK tickstock newsroom · 23:26, 11 May 2026
Trellus Health suspends AIM trading as funding options run short tickstock newsroom · 18:32, 11 May 2026
Physiomics launches board-led strategic review and says cash runway extends into 2027 tickstock newsroom · 17:05, 11 May 2026
Imaging Biometrics subsidiary Kirkstall wins grant for 'tumour on a chip' tickstock newsroom · 16:50, 11 May 2026
Avacta says pre|CISION releases payload faster and more selectively than approved ADCs tickstock newsroom · 11:09, 6 May 2026
Abingdon Health named CDMO and manufacturer for 4TEEN4's diagnostic tickstock newsroom · 09:05, 6 May 2026
Health & Bio Today: BSF Enterprise auctions T-Rex leather at Drouot, genedrive, ImmuPharma, Creo Medical, hVIVO tickstock newsroom · 17:03, 5 May 2026
Fusion Antibodies shares dip after year-end trading statement tickstock newsroom · 09:54, 5 May 2026 · Updated 14:35, 5 May
Creo Medical device used in novel BEAM bariatric procedures by US pioneer tickstock newsroom · 09:57, 5 May 2026
genedrive's MT-RNR1 test moved to routine use at Sussex NHS trust tickstock newsroom · 09:54, 5 May 2026
BSF Enterprise to auction world's first T‑Rex Leather handbag at Drouot tickstock newsroom · 09:54, 5 May 2026
The Premarket Brief: Vodafone buys out VodafoneThree, HSBC, Kodal Minerals, Plus500 ... tickstock newsroom · 08:05, 5 May 2026
ImmuPharma launches IND‑enabling programme for Kapiglucagon with tranScrip tickstock newsroom · 08:01, 5 May 2026
OptiBiotix bolsters working capital with sale of SkinBioTherapeutics shares tickstock newsroom · 13:41, 1 May 2026
Seaport Therapeutics prices $254.9m Nasdaq IPO, London-listed PureTech gets a lift tickstock newsroom · 08:37, 1 May 2026
Shield Therapeutics reports 54% growth in ACCRUFeR sales, but warns over impact of Medicaid changes tickstock newsroom · 08:24, 1 May 2026
Market reports Daily reports The Premarket Brief London LIVE Small Caps Today Sector reports Mining Today Oil & Gas Today Health & Bio Today Tech Today
Energy & Resources Topics Oil & Gas Mining & Metals Renewables Nuclear Top Stocks AAL Anglo American ANTO Antofagasta FRES Fresnillo EDV Endeavour Mining GGP Greatland Gold See all companies
Financials Topics Banks Insurance Asset Management Fintech & Payments REITs & Property Top Stocks BARC Barclays HSBA HSBC LLOY Lloyds NWG NatWest AV. Aviva PRU Prudential See all companies
Technology Topics Software & SaaS Semiconductors AI & Machine Learning Cybersecurity Top Stocks SGE Sage Group RPI Raspberry Pi KNOS Kainos SCT Softcat See all companies
Healthcare Topics Pharma Biotech Medtech Healthcare Services Top Stocks AZN AstraZeneca GSK GSK SN. Smith & Nephew HIK Hikma See all companies
Industrials Topics Aerospace & Defence Construction Engineering Transport & Logistics Top Stocks BA. BAE Systems RR. Rolls-Royce BAB Babcock QQ. QinetiQ CHG Chemring See all companies
Consumer Topics Retail Food & Beverage Travel & Leisure Media & Entertainment Top Stocks DGE Diageo ULVR Unilever TSCO Tesco NXT Next See all companies
